Skip to content
Sign In

Main Navigation

James Sharp Logo
  • Individuals
    Individuals

    Choose Your Level of Service

    • Discretionary ServiceDiscretionary Service
    • Execution Only ServiceExecution Only Service
  • Charities & Trustees
    Charities & Trustees

    Choose Your Level of Service

    • Discretionary ServiceDiscretionary Service
    • Execution Only ServiceExecution Only Service

  • Companies
    Companies

    Choose Your Level of Service

    • Discretionary ServiceDiscretionary Service
    • Execution Only ServiceExecution Only Service

  • News & Insights
    • News & Insights
    • Current Research Coverage List
  • About Us
    • About Us
    • Our People
  • Conectus Portal
  • Contact Us

Update - Page 13

11 February 2026

Coca-Cola – 2025 Full Year Results

Strong execution and financial performance in 2025 Coca-Cola HBC AG, a growth-focused Consumer Packaged Goods business and strategic bottling partner of The Coca-Cola Company,…

11 February 2026

Renishaw – Half Year Results FY2026

HALF YEAR RESULTS FY2026 Renishaw, a world leader in measuring and manufacturing systems, today announces its interim results for the six months ended 31…

10 February 2026

AstraZeneca Results: FY & Q4 2025

Strong commercial performance and excellent pipeline delivery in a continuing catalyst-rich period Revenue and EPS summary FY 2025          % Change Q4 2025         …

10 February 2026

GSK – China CDE Accepts Arexvy Adults 60+ Application

GSK’s RSV vaccine, Arexvy, accepted for regulatory review in China for adults aged 60 years and older GSK plc (LSE/NYSE: GSK) today announced that…

9 February 2026

Wynnstay Group – Final Results

Wynnstay Group plc (“Wynnstay” or “the Group” or “the Company”) Agricultural supplies and services group Final Results for the year ended 31 October 2025…

6 February 2026

GSK’s Nucala COPD Approved by the European Commission

Nucala (mepolizumab) approved by the European Commission for the treatment of chronic obstructive pulmonary disease (COPD) GSK plc (LSE/NYSE: GSK) today announced the European Commission…

6 February 2026

Amazon.com Announces Q4 2025 Results

SEATTLE–(BUSINESS WIRE)– Amazon.com, Inc. (NASDAQ: AMZN) today announced financial results for its fourth quarter ended December 31, 2025. Fourth Quarter 2025 Full Year 2025 “AWS…

6 February 2026

Alphabet Announces Q4 & Fiscal Year 2025 Results

MOUNTAIN VIEW, Calif. – February 4, 2026 – Alphabet Inc. (NASDAQ: GOOG, GOOGL) today announced financial results for the quarter ended December 31, 2025….

Posts navigation

  • «
  • 1
  • …
  • 11
  • 12
  • 13
  • 14
  • 15
  • …
  • 86
  • »

Home > Update > Page 13

James Sharp white Logo
Sign In
Linkedin Icon

The Exchange
5 Bank Street
Bury, Lancashire
BL9 0DN

Tel: 0161 764 4043

Fax: 0161 764 1628

Email: mail@jamessharp.co.uk

Linkedin Icon

James Sharp & Co is a trading name
of James Sharp & Co LLP (0C422665)

Members of the LLP are referred to as Partners

  • Downloads & Resources
  • Complaints
  • Financial Compensation Scheme
  • Conectus Portal

  • Cyber Essentials Certification
  • Website Terms & Conditions
  • Privacy Policy
  • Cookie policy
  • Consent Preferences

Email Newsletter Sign-up

Consent(Required)
What we do with you information. Find out more

© Copyright 2010-2026. All rights reserved. James Sharp & Co. Authorised & Regulated by the Financial Conduct Authority
Member of the London Stock Exchange - Member of the Aquis Stock Exchange - Member of PIMFA

Website by ICG